President & Chief Executive Officer
Saeed Motahari joined INSYS Therapeutics as President and Chief Executive Officer in April 2017. Prior to joining INSYS, Mr. Motahari served as Chief Commercial Officer at Purdue Pharma L.P., where he lead a successful transformation of the commercial organization and contributed to the business development strategy, since May 2014.
Prior to Purdue, Mr. Motahari worked at Abbott Laboratories and AbbVie, serving as Vice President of U.S. Specialty Brands – New Launches, from 2004–2014. He also held P&L responsibility for Specialty Franchises in the Renal, Oncology, Endocrinology, Acute Care, Virology and Neuroscience therapeutic areas. In addition, Mr. Motahari led various commercial organizations at Abbott Laboratories, Bristol-Myers Squibb and Hoffmann-La Roche in managed care, commercial operations, global analytics and new product development.
Mr. Motahari received a BS in Biology and holds a Master’s of Business degree from Concordia University, Montreal, Canada.